Collagenase Clostridium histolyticum Injection Therapy Improves Health-related Quality of Life in Patients with Dupuytren’s Disease

OBJECTIVES: This study was conducted to investigate the changes in clinical and psychosocial outcomes in patients with Dupuytren’s disease after initial treatment with collagenase Clostridium histolyticum (CCH) injection. METHODS: This study involved 14 patients with Dupuytren’s disease who underwen...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuboi, Takuro, Tajika, Tsuyoshi, Endo, Fumitaka, Goto, Wataru, Nakajima, Ichiro, Hasegawa, Satoshi, Nakajima, Daisuke, Hosokawa, Takafumi, Chikuda, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JARM 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149854/
https://www.ncbi.nlm.nih.gov/pubmed/34056142
http://dx.doi.org/10.2490/prm.20210023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149854/
https://www.ncbi.nlm.nih.gov/pubmed/34056142
http://dx.doi.org/10.2490/prm.20210023

Ejemplares similares